These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 919806)

  • 1. [The action spectrum of cytostatics in the management of glomerulonephritis].
    Kakuk G; Szabó J; Löcsey L; Szabó T
    Z Urol Nephrol; 1977 Aug; 70(8):595-602. PubMed ID: 919806
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of chronic glomerulonephritis with cytostatics].
    Tareeva IE; Gordovskaia NB; Gladskikh OP; Ivanov AA; Krasnova TN
    Ter Arkh; 1989; 61(6):9-14. PubMed ID: 2799726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunosuppressive therapy (cytostatics) in glomerulonephritis].
    Ricken D
    Verh Dtsch Ges Inn Med; 1972; 78():766-70. PubMed ID: 4665751
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of combined immunosuppressive-cytostatic treatment on antibody-dependent cellular cytotoxicity of patients with chronic glomerulonephritis.
    Láng I; Fekete B; Kenéz B; Nagy ZK; Gergely P
    Acta Med Acad Sci Hung; 1977; 34(4):247-50. PubMed ID: 618056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Primary glomerulopathies--therapy using corticosteroids and cytostatics (immunosuppressive agents)].
    Lagrue G; Bariéty J
    Munch Med Wochenschr; 1970 Mar; 112(12):515-22. PubMed ID: 5467836
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of primary glomerulonephritis. Comparative study on the effect of cytostatics-prednisone and cytostatics-anticoagulant-aggregation inhibitor combination].
    Schmitt E; Kröger E; Lakner V; Klinkmann H; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1979 Sep; 34(17):465-71. PubMed ID: 539014
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prednisolone and azathioprine in membranous nephropathy: a 10-year follow-up study.
    Goumenos DS; Ahuja M; Davlouros P; El Nahas AM; Brown CB
    Clin Nephrol; 2006 May; 65(5):317-23. PubMed ID: 16724651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Results of immunosuppressive therapy of chronic glomerulonephritis in 400 patients].
    Müller V; Natusch R; Göbel U; Laske HR; Sperschneider H; Pap I; Sinn W; Koall W; Achenbach H; Tredt HJ
    Z Urol Nephrol; 1985 Jan; 78(1):39-55. PubMed ID: 3976309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytotoxic drug treatment of lupus nephritis.
    Donadio JV; Holley KE; Ilstrup DM
    Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):178-81. PubMed ID: 7102666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasmapheresis in the combined therapy of progressive forms of glomerulonephritis].
    Moskaleva ES; Ignatova MS; Korneeva VA; Muromtsev IuV; Tsvetkova EI; Parubinovskaia NM; Kharina EA; Katysheva OV; Krivonos AV
    Ter Arkh; 1994; 66(6):42-5. PubMed ID: 7940367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and therapy of chronic glomerulonephritis in long-term follow-up].
    Sinn W
    Z Urol Nephrol; 1986 Feb; 79(2):59-66. PubMed ID: 3705778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glomerulonephritis therapy. Immunosuppression or coagulation inhibitors - a comparison].
    Schmitt E; Sinn W; Lakner V; Ratner M; Tomilina N
    Z Gesamte Inn Med; 1980 Aug; 35(15):Suppl 45-8. PubMed ID: 7467565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination therapy using prednisolone and cyclophosphamide slows the progression of moderately advanced IgA nephropathy.
    Tsuruya K; Harada A; Hirakata H; Mitsuiki K; Johko T; Kondoh H; Takechi S; Fujishima M
    Clin Nephrol; 2000 Jan; 53(1):1-9. PubMed ID: 10661476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Possibilities of combined treatment of diffuse collagenous glomerulonephritis].
    Belovezhdov N; Tsekova D; Dzherasi R; Gruev I; Kiperova B
    Vutr Boles; 1982; 21(5):25-34. PubMed ID: 7164403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined immunosuppressive anticoagulant and antiplatelet therapy of the course of chronic mesangial-proliferative glomerulonephritis.
    Matousovic K; Matl I; Zabka J; Zástava V; Rossmann P; Prát V
    Czech Med; 1985; 8(3):151-7. PubMed ID: 3932033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Indications for immunosuppressive treatment in kidney diseases of children].
    Wojnarowski M; Wyszyńska T
    Pediatr Pol; 1969 May; 44(5):525-30. PubMed ID: 4183009
    [No Abstract]   [Full Text] [Related]  

  • 17. [Immunosuppressive treatment of glomerulonephritis].
    Attman PO; Bengtsson U
    Lakartidningen; 1975 Apr; 72(16):1663-8. PubMed ID: 1128073
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunodepressant drugs in the treatment of glomerulonephritis.
    Cameron JS
    J Ir Med Assoc; 1971 Sep; 64(419):466-7. PubMed ID: 5118862
    [No Abstract]   [Full Text] [Related]  

  • 19. The therapy of idiopathic membranous glomerulonephritis.
    Glassock RJ
    Semin Nephrol; 1991 Mar; 11(2):138-47. PubMed ID: 2034923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytotoxic drug therapy in steroid-resistant glomerulonephritis.
    White RH
    Proc R Soc Med; 1967 Nov; 60(11 Part 1):1164-8. PubMed ID: 6060717
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.